Study to Evaluate the Effect of LY2189265 on Sitagliptin Pharmacokinetics in Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase I
Latest Information Update: 18 Mar 2017
At a glance
- Drugs Dulaglutide (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 18 Mar 2017 Results evaluating pharmacokinetic interaction between Dulaglutide and Sitagliptin in patients with type 2 diabetes, presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 27 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.